REGN - Spark Newswire

5 minute read

The Daily Biotech Pulse: Cara’s Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

Today, 1:47 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23)

ABBV

1 minute read

Regeneron Announces Topline Phase 2 Data Of High-Dose aflibercept In Wet Age-related Macular Degeneration

By Bill Haddad

Today, 1:47 PM

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that an ongoing Phase 2 proof-of-concept trial evaluating an investigational 8 mg dose of aflibercept met its primary safety endpoint,

REGN

2 minute read

Earnings

Return on Capital Employed Insights for Regeneron Pharmaceuticals

By Benzinga Insights

Today, 1:47 PM

After pulling data from Benzinga Pro it seems like during Q2, Regeneron Pharmaceuticals (NASDAQ:REGN) earned $3.35 billion, a 200.82% increase from the preceding quarter.

REGN

4 minute read

Stocks That Hit 52-Week Highs On Friday

By Benzinga Insights

Today, 1:47 PM

Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs.

1 minute read

UK Approves Regeneron – Roche’s COVID-19 Antibody Cocktail

By Vandana Singh

Today, 1:47 PM

The U.K. drug regulator has approved an antibody cocktail developed by Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Roche Holding AG (OTC:RHHBY) to…

REGN

6 minute read

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

By Shanthi Rexaline

Today, 1:47 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19)

ABVC

4 minute read

FDA
News

Regeneron Reports UK Authorized Its Antibody Cocktail To Prevent, Treat Acute COVID-19 Infection

By Benzinga Newsdesk

Today, 1:47 PM

UK chief medical officers to confirm how antibody cocktail will be rolled-out on the National Health Service (NHS) in the coming weeks In the U.S., Regeneron has completed the first FDA BLA submission for the antibody

REGN

1 minute read

FDA
News

Regeneron Granted FDA Orphan Drug Designation For ‘Treatment of stage IA2 to stage IV cervical cancer’

By Benzinga Newsdesk

Today, 1:47 PM

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=671518

REGN

1 minute read

Cathie Wood’s ARK Invest Posts Fund Sales For Wednesday, Aug. 18, 2021: TXG, SRPT, RHHBY, REGN, PSTI, NVS, MCRB, SQ, DOCU, PRLB, NTDOY, NSTG, XONE, BIDU, SHOP

By Michael Horton

Today, 1:47 PM

10x Genomics (TXG) - 48,490 Sarepta Therapeutics (SRPT) - 73,604 Roche (RHHBY) - 140,600 Regeneron Pharmaceuticals (REGN) - 19,393 Pluristem Therapeutics (PSTI) - 9,907 Novartis (NVS) - 52,621 Seres Therapeutics

BIDU